相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progressive multifocal leukoencephalopathy treated with nivolumab
Ethan Hoang et al.
JOURNAL OF NEUROVIROLOGY (2019)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Can Immune Checkpoint Inhibitors Keep JC Virus in Check?
Igor J. Koralnik
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab
Sebastian Rauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab
Ondine Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene et al.
JOURNAL OF AUTOIMMUNITY (2018)
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event
Joseph R. Berger et al.
JOURNAL OF NEUROVIROLOGY (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Martin Martinot et al.
EMERGING INFECTIOUS DISEASES (2018)
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
Antonio Carotenuto et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+T-lymphocytopenia treated with mirtazapine and mefloquine
Aruna Nambirajan et al.
NEUROLOGY INDIA (2017)
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system
Dennis W. Raisch et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Repeated decrease of CD4+T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
Matthieu Lavielle et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma
Yutaka Tsutsumi et al.
LEUKEMIA & LYMPHOMA (2015)
Circulating CD4+T-cell number decreases in rheumatoid patients with clinical response to rituximab
Silvia Piantoni et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1
Mireia Sospedra et al.
CLINICAL INFECTIOUS DISEASES (2014)
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era
J. L. Casado et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7
Karl B. Alstadhaug et al.
JAMA NEUROLOGY (2014)
Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
Rowan Wathes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Increased Program Cell Death-1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy
Chen Sabrina Tan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial
Clifton O. Bingham et al.
ARTHRITIS AND RHEUMATISM (2010)
Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy
Marco Tuccori et al.
ONCOLOGIST (2010)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Detection of JC Virus DNA and Proteins in the Bone Marrow of HIV-Positive and HIV-Negative Patients: Implications for Viral Latency and Neurotropic Transformation
Chen S. Tan et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Re: Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized trials
Marco Tuccori et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy
Guillaume Lefevre et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
PML-IRIS in patients with HIV infection Clinical manifestations and treatment with steroids
K. Tan et al.
NEUROLOGY (2009)
Detection of JC Virus DNA Fragments but Not Proteins in Normal Brain Tissue
Georgina Perez-Liz et al.
ANNALS OF NEUROLOGY (2008)
Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Blockade of CD11a by efalizurnab in psoriasis patients induces a unique state of T-cell hyporesponsiveness
Emma Guttman-Yassky et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice
Jean-David Bouaziz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A
Moti L. Chapagain et al.
VIROLOGY (2007)
Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution
Shilpi Narula et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone
Daniele Focosi et al.
ANTIVIRAL RESEARCH (2007)
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis
J. F. Viallard et al.
INFECTION (2007)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders:: Impact of novel therapies
J García-Suárez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Progressive multifocal leukoencephalopathy in transplant recipients
D Shitrit et al.
TRANSPLANT INTERNATIONAL (2004)
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia
T Teramoto et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
K Warnatz et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Traffic of JC virus from sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy
BF Sabath et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy
N Sacktor
JOURNAL OF NEUROVIROLOGY (2002)
HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
N Sacktor et al.
NEUROLOGY (2001)
分享论文
